SIBN SI-BONE Inc

Price (delayed)

$17.07

Market cap

$703.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.09

Enterprise value

$710.06M

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a ...

Highlights
SI-BONE's quick ratio has increased by 32% YoY and by 8% QoQ
The EPS rose by 31% YoY and by 3.5% QoQ
The equity has soared by 76% YoY but it fell by 2.3% QoQ
SI-BONE's gross margin has decreased by 7% YoY

Key stats

What are the main financial stats of SIBN
Market
Shares outstanding
41.2M
Market cap
$703.37M
Enterprise value
$710.06M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.23
Price to sales (P/S)
4.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.93
Earnings
Revenue
$144.05M
EBIT
-$39.61M
EBITDA
-$34.18M
Free cash flow
-$22.83M
Per share
EPS
-$1.09
Free cash flow per share
-$0.56
Book value per share
$4.03
Revenue per share
$3.52
TBVPS
$5.47
Balance sheet
Total assets
$223.71M
Total liabilities
$58.18M
Debt
$38.73M
Equity
$165.54M
Working capital
$182.77M
Liquidity
Debt to equity
0.23
Current ratio
9.76
Quick ratio
8.63
Net debt/EBITDA
-0.2
Margins
EBITDA margin
-23.7%
Gross margin
78.1%
Net margin
-29.9%
Operating margin
-33.1%
Efficiency
Return on assets
-18.8%
Return on equity
-25.1%
Return on invested capital
-20.7%
Return on capital employed
-19.5%
Return on sales
-27.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SIBN stock price

How has the SI-BONE stock price performed over time
Intraday
1.55%
1 week
0.59%
1 month
40.26%
1 year
-32.02%
YTD
-18.68%
QTD
32.02%

Financial performance

How have SI-BONE's revenue and profit performed over time
Revenue
$144.05M
Gross profit
$112.5M
Operating income
-$47.68M
Net income
-$43.12M
Gross margin
78.1%
Net margin
-29.9%
SI-BONE's net margin has increased by 37% YoY and by 4.2% from the previous quarter
The company's operating margin rose by 29% YoY and by 2.1% QoQ
The company's revenue rose by 23% YoY and by 3.7% QoQ
SI-BONE's net income has increased by 22% YoY

Growth

What is SI-BONE's growth rate over time

Valuation

What is SI-BONE stock price valuation
P/E
N/A
P/B
4.23
P/S
4.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.93
The EPS rose by 31% YoY and by 3.5% QoQ
The equity has soared by 76% YoY but it fell by 2.3% QoQ
SIBN's P/B is 26% below its 5-year quarterly average of 5.6 and 13% below its last 4 quarters average of 4.8
The P/S is 37% less than the 5-year quarterly average of 7.6 and 24% less than the last 4 quarters average of 6.3
The company's revenue rose by 23% YoY and by 3.7% QoQ

Efficiency

How efficient is SI-BONE business performance
The ROE has soared by 54% YoY and by 11% from the previous quarter
SI-BONE's ROA has increased by 46% YoY and by 8% from the previous quarter
The ROS rose by 38% YoY and by 4.2% QoQ
The ROIC has grown by 38% YoY and by 9% from the previous quarter

Dividends

What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SIBN.

Financial health

How did SI-BONE financials performed over time
SIBN's total assets has surged by 50% year-on-year but it is down by 2.9% since the previous quarter
SI-BONE's quick ratio has increased by 32% YoY and by 8% QoQ
SI-BONE's debt is 77% less than its equity
The equity has soared by 76% YoY but it fell by 2.3% QoQ
The debt to equity has declined by 45% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.